长非编码RNAs在肌缩侧面硬化症中的作用
Darya Rajabi1, Shaghayegh Khanmohammadi1,2,3, Nima Rezaei2,3,4
1School of Medicine, Tehran University of Medical Sciences, Felestin St., Keshavarz Blvd., Tehran, 1416634793, Iran.
Reviews in the neurosciences
|March 7, 2024
概括
长非编码RNAs (lncRNAs) 正在成为肌缩侧面硬化症 (ALS) 病原发生的关键参与者. 本综述探讨了它们在疾病机制中的作用,以及它们作为诊断和治疗点的潜力.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种致命的神经退行性疾病,具有复杂的病理机制,阻碍了诊断和治疗.
- 长非编码RNAs (lncRNAs) 越来越多地被认为是它们在细胞过程和疾病病理中的调节作用.
- 包括ALS在内的神经退行性疾病显示出与lncRNA参与有前途的联系.
研究的目的:
- 审查特定的lncRNAs的参与,如NEAT1和反感 lncRNAs (as-lncRNAs),在ALS的发病过程中.
- 讨论 lncRNAs 导致 ALS 的机制,包括基因表达调节和细胞反应.
- 评估lncRNAs作为ALS生物标志物和治疗剂的当前和未来潜力.
主要方法:
- 文献综述侧重于研究ALS中的lncRNAs的研究.
- 对已知的ALS相关基因和蛋白质 (例如,TDP-43,FUS,SOD1) 的 lncRNA 作用的分析.
- 讨论特定的lncRNAs如NEAT1和as-lncRNAs (例如ZEB1-AS1,ATXN2-AS) 以及它们的病理贡献.
主要成果:
- NEAT1通过斑形成,应激反应,炎症和亡,与ALS的发病有关.
- 鉴定出像ZEB1-AS1和ATXN2-AS这样的反感性lncRNAs为ALS病理学的新型贡献者.
- lncRNAs在调节与ALS相关的基因表达方面表现出显著的潜力.
结论:
- lncRNAs,包括NEAT1和as-lncRNAs,在ALS复杂的发病过程中发挥着关键作用.
- 这些分子为开发新型诊断生物标志物和ALS治疗策略提供了有希望的途径.
- 对lncRNA应用的进一步研究对于推进ALS治疗和理解至关重要.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Types of RNA
5.8K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.8K
RNA Splicing
56.3K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.3K
Alternative RNA Splicing
21.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.1K
Formation of Muscle Fibers from Myoblasts
4.9K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
4.9K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K


